Form 4: Surmodics Director David Dantzker Reports Stock Transactions
SEC Form 4 Filing
Director David Dantzker reports stock transactions including option exercises and share disposals at Surmodics Inc.
Summary
- On February 13, 2025, David Dantzker, a director of Surmodics Inc., executed transactions involving the company's common stock.
- Dantzker exercised stock options to acquire 5,275 shares at a price of $27.30 per share.
- Following the exercise, Dantzker disposed of 4,216 shares at a price of $34.16 per share.
- After these transactions, Dantzker beneficially owns 40,183 shares of Surmodics Inc.
- This amount includes 15,772 restricted stock units (RSUs) and 15,415 deferred stock units (DSUs).
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company leadership.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 02/13/2025 | Date of stock option exercise and share disposal. |
| 02/18/2025 | Date of signature for the Form 4 filing. |
| 02/20/2025 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.